Showing results (1-10 of 128) with videos related to
Sort By:
Pageof 13
Expert Review of Vaccines|June 24, 2009
Future of polio vaccinesEllie Ehrenfeld, John Modlin, Konstantin ChumakovClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 8, 2008
New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitisKonstantin Chumakov, Ellie EhrenfeldNature Reviews. Microbiology|October 30, 2007
Vaccination against polio should not be stoppedKonstantin Chumakov, Ellie Ehrenfeld, Eckard Wimmer, et al.The Lancet. Global Health|June 12, 2021
Polio eradication at the crossroadsKonstantin Chumakov, Ellie Ehrenfeld, Vadim I Agol, et al.Cell Cycle (Georgetown, Tex.)|January 25, 2007
Involvement of cellular membrane traffic proteins in poliovirus replicationGeorge A Belov, Ellie EhrenfeldProceedings of the National Academy of Sciences of the United States of America|November 3, 2010
Massively parallel sequencing for monitoring genetic consistency and quality control of live viral vaccinesAlexander Neverov, Konstantin ChumakovFrontiers in Immunology|March 13, 2026
Host-targeted oral avian vaccine virus demonstrates broad antiviral activity and safety in patientsTibor Bakacs, Konstantin ChumakovBiologicals : Journal of the International Association of Biological Standardization|February 17, 2005
Improved ELISA test for determination of potency of Inactivated Poliovirus Vaccine (IPV)Gennady Rezapkin, Eugenia Dragunsky, Konstantin ChumakovJournal of Virological Methods|April 26, 2011
MAPREC assay for quantitation of mutants in a recombinant flavivirus vaccine strain using near-infrared fluorescent dyesBella Bidzhieva, Majid Laassri, Konstantin ChumakovBiologicals : Journal of the International Association of Biological Standardization|February 17, 2005
Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA methodGennady Rezapkin, Javier Martin, Konstantin ChumakovPageof 13